Summary
Hepatic glucose production and peripheral glucose utilisation were measured in vivo with the euglycaemic-hyper-insulinaemic clamp technique in rats rendered severely diabetic with streptozotocin (45 mg/kg) and in control rats. The rats were studied in the post-absorptive state while anaesthetised. The basal glucose production and glucose utilisation were significantly higher (p<0.001) in diabetic rats 9 days after streptozotocin administration. During the clamp studies, suppression of glucose production by the liver induced by submaximal or maximal insulin levels was significantly less (p<0.01 and p<0.001 respectively) effective in diabetic rats as compared to control rats. Glucose utilisation was significantly lower following both submaximal (p<0.01) or maximal (p<0.001) hyperinsulinaemia as compared to control rats. Oral administration of vanadate (0.2mg/ml in drinking water) for a 20-day period in diabetic rats lowered their plasma glucose levels to normal near values within 4 days, normalised plasma insulin levels, and increased pancreatic insulin stores. The rate of glucose disappearance (K value) and in vivo glucose-induced insulin secretion as estimated during an i.v. glucose tolerance test were not significantly improved. In control rats, vanadate treatment did not significantly affect any of the above parameters. In vanadate treated diabetic rats, basal glucose production was normalised. Following submaximal or maximal hyperinsulinaemia, glucose production was suppressed normaly. Basal glucose utilisation was restored and returned to normal values during submaximal hyperinsulinaemia. However, during maximal hyperinsulinaemia, glucose utilisation still remained significantly lower (p<0.05) as compared to vanadate-treated control rats. Vanadate treatment in control rats did not affect significantly any of the above parameters. These results show an insulin-like effect of vanadate upon glucose metabolism in vivo in the liver and peripheral tissues of diabetic rats, leading to normalisation of glycaemia in the absence of any significant improvement of insulin secretion.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Heyliger CE, Tahiliani AG, McNeill JH (1985) Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats. Sciences 227: 1474–1477
Meyerovitch J, Farvel Z, Sack J, Shechter Y (1987) Oral administration of vanadate normalizes blood glucose levels in streptozotocin-treated rats. J Biol Chem 262: 6658–6662
Kergoat M, Portha B (1985) In vivo hepatic and peripheral insulin sensitivity in rats with non-insulin-dependent diabetes induced with streptozotocin. Assessment with the insulin-glucose clamp technique. Diabetes 34: 1120–1126
Leturque A, Burnol AF, Ferre P, Girard J (1984) Pregnancy induced insulin resistance in the rat. Assessment by glucose clamp technique. Am J Physiol 245: E1–7
Portha B (1985) Decreased glucose-induced insulin release and biosynthesis by islets of rats with non-insulin-dependent diabetes: Effect of tissue culture. Endocrinology 117: 1735–1741
Leahy JL, Cooper HE, Deal DA, Weir GC (1986) Chronic hyperglycemia is associated with impaired glucose influence on insulin secretion. J Clin Invest 77: 908–915
Kergoat M, Bailbe D, Portha B (1987) Insulin treatment improves glucose-induced insulin release in rats with NIDDM induced by streptozotocin. Diabetes 36: 971–977
Rossetti L, Shulman GI, Zawalich W, De Fronzo RA (1987) Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats. J Clin Invest 80: 1037–1044
Fagin JA, Ikejiri K, Levin SR (1987) Insulinotropic effects of vanadate. Diabetes 36: 1448–1452
Gil J, Miralpeix M, Carreras J, Bartrons R (1988) Insulin-like effects of vanadate on glucokinase activity and fructose 2,6-bisphosphate levels in the liver of diabetic rats. J Biol Chem 263: 1868–1871
Ramasarma T, Mackellar WC, Grave FL (1981) Vanadate-stimulated NADH oxidation in plasma membrane. Biochem Biophys Acta 646: 88–98
Ghanshyam KS, Speeg KV Jr, Cohen S, Garbers DL (1982) Phosphotyrosyl-protein phosphatase of TCRC-2 cells. J Biol Chem 13: 7298–7301
Nechay BR, Nanninga LB, Nechay PSE, Post RL, Grantham JJ, Macara IG, Kubena LF, Phillips TD, Nielsen FH (1986) Role of vanadium in biology. Fed Proc 45: 123–132
Dubyak GR, Kleinzeller A (1980) The insulin-mimetic effects of vanadate in isolated rat adipocytes. Dissociation from effects of vanadate as a (Na+-K+)ATPase inhibitor. J Biol Chem 255: 5306–5312
Tamura S, Brown TA, Whipple JH, Fujita-Yamaguchi Y, Dubler RE, Cheng K, Larner J (1984) A novel mechanism for the insulin-like effect of vanadate on glycogen synthase in rat adipocytes. J Biol Chem 259: 6650–6658
Green A (1986) The insulin-like effect of sodium vanadate on adipocyte glucose transport is mediated at a post-insulin-receptor level. Biochem J 238: 663–669
Simons TJB (1979) Vanadate — a new tool for biologists. Nature 281: 337–338
Macara IG (1986) Activation of 45Ca2+ influx and 22Na+/H+ exchange by epidermal growth factor and vanadate in A431 cells is independent of phosphatidylinositol turnover and is inhibited by phorbol ester and diacylglycerol. J Biol Chem 261: 9321–9327
Portha B, Blondel O (1988) Insulin resistance in rats with non-insulin dependent diabetes induced by neonatal (5 days) streptozotocin: evidence for reversal following phlorizin treatment. Diabetologia 31: 532 A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blondel, O., Bailbe, D. & Portha, B. In vivo insulin resistance in streptozotocin-diabetic rats — evidence for reversal following oral vanadate treatment. Diabetologia 32, 185–190 (1989). https://doi.org/10.1007/BF00265092
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00265092